Clinical Course and Pharmacokinetics Following a Massive Overdose of Amphotericin B in a Neonate
Authors:
Gideon Koren a;
Alan Lau b;
Cynthia F. Kenyon c;
David Kroppert c;
Julia Klein a
| Affiliations: | a Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto |
| b Division of Infectious Diseases, The Hospital for Sick Children, Toronto | |
| c Neonatal Perinatal Medicine, St. Joseph's Health Centre, London, Ontario |
DOI:
10.3109/15563659008994438
Publication Frequency:
10 issues per year
Subject:
Clinical Toxicology;
Formats available:
PDF
(English)
Previously published as:
Journal of Toxicology: Clinical Toxicology
(0731-3810)
until 2005
View Article:
View Article (PDF)
Abstract
Amphotericin is the drug of choice for the treatment of fungal infections in infants and children. When used in the recommended doses, amphotericin therapy is associated with high rates of adverse effects, including nephrotoxicity, hepatotoxicity, decrease in white blood cells, platelets and hemoglobin, chills, fever and even death (1). We report a case involving a neonate who was exposed to a 50 fold overdose of Amphotericin over a three day period.
|
| view references (9) |


Download Citation
CiteULike
Del.icio.us
BibSonomy
Connotea